Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ALI Pharmaceutical Manufacturing is a contract development and manufacturing organization (CDMO) that specializes in the formulation and production of liquid and semi-solid pharmaceutical dosage forms. Located in Winchester, Kentucky, the company offers services ranging from early-stage development and pilot batches to full-scale commercial manufacturing and packaging. The facility is known for its expertise in handling complex formulations, including creams, ointments, gels, and oral liquids. In 2006, ALI was acquired by Cardinal Health to bolster its pharmaceutical technologies and services segment, which was subsequently spun off to form Catalent in 2007. Today, the Winchester site remains a core component of Catalent's global manufacturing network, serving a diverse range of pharmaceutical and consumer health clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ALI Pharmaceutical Manufacturing.